Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
The former Kate Middleton was diagnosed with cancer early in 2024, and much speculation about the state of her health has followed. Catherine, Princess of Wales, has since shared that she ...
The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.
The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...
1d
The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.
Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback